» Articles » PMID: 22662226

Perivascular Expression and Potent Vasoconstrictor Effect of Dynorphin A in Cerebral Arteries

Overview
Journal PLoS One
Date 2012 Jun 5
PMID 22662226
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Numerous literary data indicate that dynorphin A (DYN-A) has a significant impact on cerebral circulation, especially under pathophysiological conditions, but its potential direct influence on the tone of cerebral vessels is obscure. The aim of the present study was threefold: 1) to clarify if DYN-A is present in cerebral vessels, 2) to determine if it exerts any direct effect on cerebrovascular tone, and if so, 3) to analyze the role of κ-opiate receptors in mediating the effect.

Methodology/principal Findings: Immunohistochemical analysis revealed the expression of DYN-A in perivascular nerves of rat pial arteries as well as in both rat and human intraparenchymal vessels of the cerebral cortex. In isolated rat basilar and middle cerebral arteries (BAs and MCAs) DYN-A (1-13) and DYN-A (1-17) but not DYN-A (1-8) or dynorphin B (DYN-B) induced strong vasoconstriction in micromolar concentrations. The maximal effects, compared to a reference contraction induced by 124 mM K(+), were 115±6% and 104±10% in BAs and 113±3% and 125±9% in MCAs for 10 µM of DYN-A (1-13) and DYN-A (1-17), respectively. The vasoconstrictor effects of DYN-A (1-13) could be inhibited but not abolished by both the κ-opiate receptor antagonist nor-Binaltorphimine dihydrochloride (NORBI) and blockade of G(i/o)-protein mediated signaling by pertussis toxin. Finally, des-Tyr(1) DYN-A (2-13), which reportedly fails to activate κ-opiate receptors, induced vasoconstriction of 45±11% in BAs and 50±5% in MCAs at 10 µM, which effects were resistant to NORBI.

Conclusion/significance: DYN-A is present in rat and human cerebral perivascular nerves and induces sustained contraction of rat cerebral arteries. This vasoconstrictor effect is only partly mediated by κ-opiate receptors and heterotrimeric G(i/o)-proteins. To our knowledge our present findings are the first to indicate that DYN-A has a direct cerebral vasoconstrictor effect and that a dynorphin-induced vascular action may be, at least in part, independent of κ-opiate receptors.

Citing Articles

Distinct neurochemical influences on fMRI response polarity in the striatum.

Cerri D, Albaugh D, Walton L, Katz B, Wang T, Chao T Nat Commun. 2024; 15(1):1916.

PMID: 38429266 PMC: 10907631. DOI: 10.1038/s41467-024-46088-z.


Putative neurochemical and cell type contributions to hemodynamic activity in the rodent caudate putamen.

Katz B, Walton L, Houston K, Cerri D, Shih Y J Cereb Blood Flow Metab. 2022; 43(4):481-498.

PMID: 36448509 PMC: 10063835. DOI: 10.1177/0271678X221142533.


Dynorphins in Development and Disease: Implications for Cardiovascular Disease.

Cissom C, Paris J, Shariat-Madar Z Curr Mol Med. 2019; 20(4):259-274.

PMID: 31746302 PMC: 7457512. DOI: 10.2174/1566524019666191028122559.


Endocannabinoids in cerebrovascular regulation.

Benyo Z, Ruisanchez E, Leszl-Ishiguro M, Sandor P, Pacher P Am J Physiol Heart Circ Physiol. 2016; 310(7):H785-801.

PMID: 26825517 PMC: 4865067. DOI: 10.1152/ajpheart.00571.2015.


Role of endocannabinoids and cannabinoid-1 receptors in cerebrocortical blood flow regulation.

Iring A, Ruisanchez E, Leszl-Ishiguro M, Horvath B, Benko R, Lacza Z PLoS One. 2013; 8(1):e53390.

PMID: 23308211 PMC: 3537620. DOI: 10.1371/journal.pone.0053390.

References
1.
Hamel E . Perivascular nerves and the regulation of cerebrovascular tone. J Appl Physiol (1985). 2006; 100(3):1059-64. DOI: 10.1152/japplphysiol.00954.2005. View

2.
Faden A, JACOBS T . Dynorphin induces partially reversible paraplegia in the rat. Eur J Pharmacol. 1983; 91(2-3):321-4. DOI: 10.1016/0014-2999(83)90487-9. View

3.
Altura B, Altura B, Quirion R . Identification of benzomorphan-kappa opiate receptors in cerebral arteries which subserve relaxation. Br J Pharmacol. 1984; 82(2):459-66. PMC: 1987038. DOI: 10.1111/j.1476-5381.1984.tb10781.x. View

4.
Uddman R, Edvinsson L . Neuropeptides in the cerebral circulation. Cerebrovasc Brain Metab Rev. 1989; 1(3):230-52. View

5.
Brugos B, Hochhaus G . Metabolism of dynorphin A(1-13). Pharmazie. 2004; 59(5):339-43. View